Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Timeline of historic inventions
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
====2020s==== * '''2020:''' The first [[MRNA vaccine]] to be approved by public health medicines regulators is co-developed by [[Pfizer]] and [[BioNTech]] for [[COVID-19]].<ref>{{Cite web |date=2021-01-14 |title=Pfizer-BioNTech COVID-19 Vaccine {{!}} FDA |website=[[Food and Drug Administration]] |url=https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-COVID-19/pfizer-biontech-COVID-19-vaccine |access-date=2024-07-11 |archive-url=https://web.archive.org/web/20210114221304/https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-COVID-19/pfizer-biontech-COVID-19-vaccine |archive-date=14 January 2021 }}</ref> * '''2020:''' [[OpenAI]] demonstrated an [[Artificial intelligence|Artificial Intelligence]] model called [[GPT-3]]. The program was created to generate human-like responses when given prompts.<ref>Kissinger, Henry; Schmidt, Eric; Huttenlocher, Daniel P. (2021). ''The age of AI: and our human future''. Schuyler Schouten (First edition ed.). New York Boston London: Little, Brown and Company. {{ISBN|978-0-316-27380-0}}.</ref> * '''2021:''' [[Pfizer]] develops [[Paxlovid|the world's first pill]] for [[COVID-19|COVID]]. * '''2022:''' [[ChatGPT]] is launched to the public, making its first mainstream [[generative AI]] to be released.
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)